Download presentation
Presentation is loading. Please wait.
Published byLaís Pinhal Farinha Modified over 6 years ago
1
Randomized Phase III Trial of Pegfilgrastim versus Filgrastim after Autologus Peripheral Blood Stem Cell Transplantation Aaron Gerds, Mary Fox-Geiman, Kevin Dawravoo, Tulio Rodriguez, Amir Toor, Scott Smith, Karen Kiley, Donna Fletcher-Gonzalez, Chindo Hicks, Patrick Stiff Biology of Blood and Marrow Transplantation Volume 16, Issue 5, Pages (May 2010) DOI: /j.bbmt Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions
2
Figure 1 Patient enrollment and movement through the study.
Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions
3
Figure 2 Neutrophil engraftment after transplant. Kaplain-Meier plot of time to an ANC of 1.5×109/L for 3 days, or 5×109/L for 1 day in the filgrastim group compared to the pegfilgrastim group. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions
4
Figure 3 Platelet count (×109/L) in the first 25 days after transplant. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions
5
Figure 4 Kaplan-Meier plot of OS in the in the filgrastim and pegfilgrastim groups. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.